Provided by Tiger Trade Technology Pte. Ltd.

Viridian Therapeutics, Inc.

22.78
-0.2500-1.09%
Post-market: 22.800.0200+0.09%19:30 EDT
Volume:1.42M
Turnover:32.20M
Market Cap:2.58B
PE:-6.59
High:23.74
Open:23.11
Low:22.39
Close:23.03
52wk High:34.29
52wk Low:13.18
Shares:113.29M
Float Shares:101.00M
Volume Ratio:1.59
T/O Rate:1.40%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.4579
EPS(LYR):-3.3245
ROE:-65.74%
ROA:-30.16%
PB:4.58
PE(LYR):-6.85

Loading ...

Viridian says elegrobart meets Phase 3 endpoint in chronic thyroid eye disease trial

Reuters
·
May 05

BRIEF-Viridian Therapeutics Q1 Revenue USD 6 Thousand Vs. IBES Estimate USD 27.5 Thousand

Reuters
·
May 05

Corrected-Viridian Therapeutics Q1 Revenue USD 141 Thousand

THOMSON REUTERS
·
May 05

Viridian Therapeutics Q1 Revenue USD 6 Thousand VS. Ibes Estimate USD 27.5 Thousand

THOMSON REUTERS
·
May 05

Viridian Therapeutics Inc - Elegrobart Bla Submission on Track for Q1 2027

THOMSON REUTERS
·
May 05

Viridian Therapeutics Inc - Veligrotug FDA Priority Review With Pdufa Target Date June 30, 2026

THOMSON REUTERS
·
May 05

Viridian Therapeutics Inc - Reveal-2 Trial Meets Primary Endpoint With Highly Statistically Significant Treatment Effect

THOMSON REUTERS
·
May 05

Viridian Therapeutics Inc - Elegrobart Generally Well Tolerated With Low Rates of Hearing Impairment

THOMSON REUTERS
·
May 05

NASDAQ TRADE HALT HALT NEWS PENDING AT 06:55 AM

Reuters
·
May 05

Analysts Offer Insights on Healthcare Companies: AptarGroup (ATR) and Viridian Therapeutics (VRDN)

TIPRANKS
·
May 01

Need To Know: The Consensus Just Cut Its Viridian Therapeutics, Inc. (NASDAQ:VRDN) Estimates For 2026

Simply Wall St.
·
Apr 21

Will Amgen’s Subcutaneous Tepezza Success Reshape Viridian Therapeutics' (VRDN) Thyroid Eye Disease Narrative?

Simply Wall St.
·
Apr 19

Viridian Therapeutics announces annual shareholder meeting webcast

Reuters
·
Apr 17

A Look At Viridian Therapeutics (VRDN) Valuation After Positive REVEAL-1 Phase 3 Elegrobart Results

Simply Wall St.
·
Apr 13

Analysts Offer Insights on Healthcare Companies: Enliven Therapeutics (ELVN), Viridian Therapeutics (VRDN) and Soleno Therapeutics (SLNO)

TIPRANKS
·
Apr 11

Analysts Have Conflicting Sentiments on These Healthcare Companies: Medtronic (MDT) and Viridian Therapeutics (VRDN)

TIPRANKS
·
Apr 10

BUZZ-Truist cuts Viridian PT after eye disease trial data

Reuters
·
Apr 08

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Apr 07

Viridian Therapeutics Inc : Wedbush Removes Stock From Its Best Ideas List

THOMSON REUTERS
·
Apr 07

Viridian Therapeutics Inc : RBC Cuts Target Price to $30 From $42

THOMSON REUTERS
·
Apr 07